Virtus ETF Advisers’s CARGO Therapeutics CRGX Stock Holding History

Virtus ETF Advisers’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-32,055	Closed	-$132K	–	478
2025 Q2	$132K	Hold	32,055	–	–	0.08%	253
2025 Q1	$130K	Buy	32,055 +27,297	+574%	+$183K	0.08%	267
2024 Q4	$68.6K	Sell	4,758 -610	-11%	-$11.1K	0.03%	391
2024 Q3	$99K	Buy	5,368 +99	+2%	+$1.77K	0.05%	377
2024 Q2	$86.5K	Buy	+5,269	New	+$100K	0.04%	376

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtus ETF Advisers's CRGX Position: Q3 2025 in Review

Virtus ETF Advisers sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 32,055 shares — an estimated $132K sold.

Virtus ETF Advisers first reported a position in CRGX in Q2 2024 and held it in 5 quarters. The position peaked at $132K in Q2 2025. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Virtus ETF Advisers reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Virtus ETF Advisers sold 32,055 CARGO Therapeutics shares in Q3 2025, an estimated $132K.
Virtus ETF Advisers first reported a position in CARGO Therapeutics in Q2 2024 and held it in 5 quarters.
Virtus ETF Advisers's CARGO Therapeutics position peaked at $132K in Q2 2025.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Virtus ETF Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.